1,2-Dichloroethane → HCID 66678954, compound
Reaction equation
Cl.[CH2:2]([NH:4][C:5]([NH:7][C:8]1[CH:13]=[CH:12][C:11]([C:14]2[N:15]=[C:16]([N:23]3[CH2:28][CH2:27][O:26][CH2:25][C@@H:24]3[CH3:29])[C:17]3[CH2:22][NH:21][CH2:20][C:18]=3[N:19]=2)=[CH:10][C:9]=1[F:30])=[O:6])[CH3:3].CN1CCOCC1.C(Cl)CCl.C1C=CC2N(O)N=NC=2C=1.[C:52]([N:55]1[CH2:60][CH2:59][CH:58]([C:61](O)=[O:62])[CH2:57][CH2:56]1)(=[O:54])[CH3:53]>CN(C=O)C>[C:52]([N:55]1[CH2:56][CH2:57][CH:58]([C:61]([N:21]2[CH2:22][C:17]3[C:16]([N:23]4[CH2:28][CH2:27][O:26][CH2:25][C@@H:24]4[CH3:29])=[N:15][C:14]([C:11]4[CH:12]=[CH:13][C:8]([NH:7][C:5]([NH:4][CH2:2][CH3:3])=[O:6])=[C:9]([F:30])[CH:10]=4)=[N:19][C:18]=3[CH2:20]2)=[O:62])[CH2:59][CH2:60]1)(=[O:54])[CH3:53]Participants
7
Procedure
A stirred solution of (S)-1-ethyl-3-(2-fluoro-4-(4-(3-methylmorpholino)-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin-2-yl)phenyl)urea (intermediate 18) (133 mg, 0.25 mmol) and N-methylmorpholine (55 μL, 0.5 mmol) in DMF (5 mL, anhydrous) was added EDC (53 mg, 0.275 mmol), HOBT (37 mg, 0.275 mmol), and 1-acetylpiperidine-4-carboxylic acid (43 mg, 0.25 mmol). The reaction mixture was stirred at room temperature until analysis by LCMS deemed reaction complete. Solvent was then removed in vacuo. Purified by prep. HPLC (low pH) Then further purified using a TsOH cartridge to remove residual formic acid from HPLC (loaded in MeOH eluted with 2M methanolic ammonia). Yielding a light pink solid (9.6 mg, 0.017 mmol, 7%).
Workup
- customreaction complete
- customSolvent was then removed in vacuo
- customPurified by prep
- customHPLC (low pH) Then further purified
- customto remove residual formic acid
- washfrom HPLC (loaded in MeOH eluted with 2M methanolic ammonia)
Sources & evidence
- ORD record
- ord-a698c6134c8440cea64ef032b23310e8
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08785457B2
Reaction notes
Loading…